Season 2 Episode 1: Scaling AI Across the Enterprise

Most biotech companies are stuck in "pilot purgatory" with Generative AI. But moving from a fun experiment to a scalable, enterprise-grade solution requires more than just a software license, it demands a fundamental shift in how IT partners with Legal, QA, and Regulatory teams.

In the Season 2 premiere of The Improzone, host Jane Urban sits down with Andrew Schwartz (Head of Global IT, KalVista Pharmaceuticals) to break down the roadmap for scaling AI across the enterprise.

In this episode, we cover:

• Shadow IT vs. Enterprise Strategy: Why moving off personal ChatGPT accounts is the first step to security.

• The "Human-in-the-Loop": How to deploy Agentic AI that assists rather than replaces.

• Cross-Functional Governance: How to get Legal and QA to say "Yes" to innovation.

If you are leading digital transformation in life sciences, this is your blueprint for 2026.

#GenerativeAI #LifeSciences #PharmaAI #BiotechInnovation #EnterpriseAI #DigitalTransformation #KalVista #TheImprozone #AIgovernance #Improzo